Melanoma survivors: could immunotherapy harm your heart years later?
NCT ID NCT06605833
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 31 times
Summary
This study looks at whether melanoma survivors who received immunotherapy (immune checkpoint inhibitors) may have long-term heart problems, such as increased risk of heart attack. Researchers will invite 60 people who finished treatment 2 to 10+ years ago to undergo heart tests. The goal is to see if this type of follow-up is possible and to gather data for a larger study that could change future care guidelines.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA STAGE III OR IV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Royal Marsden NHS Foundation Trust
London, SW6 3JJ, United Kingdom
Conditions
Explore the condition pages connected to this study.